Drake Debra A 4
4 · Trevi Therapeutics, Inc. · Filed May 13, 2019
Insider Transaction Report
Form 4
Drake Debra A
10% Owner
Transactions
- Conversion
Common Stock
2019-05-09+52,141→ 52,141 total - Conversion
Common Stock
2019-05-09+10,399→ 10,399 total(indirect: By Spouse) - Conversion
Series A Preferred Stock
2019-05-09−58,153→ 0 total→ Common Stock (8,482 underlying) - Conversion
Series A Preferred Stock
2019-05-09−75,000→ 0 total(indirect: By Spouse)→ Common Stock (10,399 underlying) - Conversion
Series C Preferred Stock
2019-05-09−376,023→ 0 total→ Common Stock (43,659 underlying)
Footnotes (2)
- [F1]On May 9, 2019, the Series A Preferred Stock, and the dividends that had accrued thereon to date, converted into Common Stock on a 9.5-for-one basis without payment of further consideration automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date.
- [F2]On May 9, 2019, the Series C Preferred Stock, and the dividends that had accrued thereon to date, converted into Common Stock on a 9.5-for-one basis without payment of further consideration automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date.